✦ LIBER ✦

Nab-Paclitaxel/Bevacizumab/Carboplatin Chemotherapy in First-Line Triple Negative Metastatic Breast Cancer

✍ Scribed by Hamilton, Erika; Kimmick, Gretchen; Hopkins, Judith; Marcom, P. Kelly; Rocha, Gloria; Welch, Renee; Broadwater, Gloria; Blackwell, Kimberly

Book ID: 123477350
Publisher: CIG Media Group, LP.
Year: 2013
Tongue: English
Weight: 261 KB
Volume: 13
Category: Article
ISSN: 1526-8209
DOI: 10.1016/j.clbc.2013.08.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel + carboplatin: first-line the

Paclitaxel + carboplatin: first-line therapy in breast cancer.

📂 Article 📅 1998 🏛 Adis International Limited (now part of Wolters Kl ⚖ 131 KB

Paclitaxel and bevacizumab in first-line

Paclitaxel and bevacizumab in first-line treatment for HER2-negative metastatic breast cancer: single-center experience

✍ Lorenzo Livi, Pierluigi Bonomo, Icro Meattini, Gabriele Simontacchi, Daniela Gre 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 170 KB

Adding bevacizumab to paclitaxel in the

Adding bevacizumab to paclitaxel in the first-line treatment of metastatic breast cancer

✍ Kevin R. Fox 📂 Article 📅 2008 🏛 Current Science Inc. 🌐 English ⚖ 186 KB

Iniparib plus Chemotherapy in Metastatic

Iniparib plus Chemotherapy in Metastatic Triple-Negative Breast Cancer

✍ O'Shaughnessy, Joyce; Osborne, Cynthia; Pippen, John E.; Yoffe, Mark; Patt, Debr 📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 596 KB

Bevacizumab in First-Line Treatment of M

Bevacizumab in First-Line Treatment of Metastatic Breast Cancer

✍ David Miles 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 46 KB

Bevacizumab in First-Line Treatment of M

Bevacizumab in First-Line Treatment of Metastatic Breast Cancer

✍ Xavier Pivot 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 45 KB